Literature DB >> 25205467

ACE2 activation by xanthenone prevents leptin-induced increases in blood pressure and proteinuria during pregnancy in Sprague-Dawley rats.

Hisham Saleh Ibrahim1, Gabrielle Ruth Anisah Froemming2, Effat Omar2, Harbindar Jeet Singh2.   

Abstract

This study investigates the effect of ACE2 activation on leptin-induced changes in systolic blood pressure (SBP), proteinuria, endothelial activation and ACE2 expression during pregnancy in Sprague-Dawley rats. Pregnant rats were given subcutaneous injection of either saline, or leptin, or leptin plus xanthenone (ACE2 activator), or xanthenone (XTN) alone. SBP, serum ACE, ACE2, endothelin-1, E-selectin and ICAM-1 levels were estimated; also their gene expressions were determined in the kidney and aorta respectively. Compared to control, SBP was higher in the leptin-only treated group (P<0.001) and lower in rats treated with xanthenone alone (P<0.01). Proteinuria, markers of endothelial activation were significantly higher than controls in leptin-only treated rats (P<0.05). ACE2 activity and expression were lower in leptin-only treated rats when compared to controls (P<0.05). It seems, leptin administration during pregnancy significantly increases SBP, proteinuria, endothelial activation, but decreases ACE2 level and expression. These effects are prevented by concurrent administration of xanthenone.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ACE2; Blood pressure; E-selectin; Endothelial activation; Endothelin-1; ICAM-1; Leptin; Proteinuria

Mesh:

Substances:

Year:  2014        PMID: 25205467     DOI: 10.1016/j.reprotox.2014.08.006

Source DB:  PubMed          Journal:  Reprod Toxicol        ISSN: 0890-6238            Impact factor:   3.143


  7 in total

1.  Uterine artery dysfunction in pregnant ACE2 knockout mice is associated with placental hypoxia and reduced umbilical blood flow velocity.

Authors:  Liliya M Yamaleyeva; Victor M Pulgar; Sarah H Lindsey; Larissa Yamane; Jasmina Varagic; Carolynne McGee; Mauro daSilva; Paula Lopes Bonfa; Susan B Gurley; K Bridget Brosnihan
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-05-12       Impact factor: 4.310

2.  Modulation of brain ACE and ACE2 may be a promising protective strategy against cerebral ischemia/reperfusion injury: an experimental trial in rats.

Authors:  Maha Mohammed Abdel-Fattah; Basim Anwar Shehata Messiha; Ahmed Mohamed Mansour
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-06-17       Impact factor: 3.000

3.  Short-term treatment with diminazene aceturate ameliorates the reduction in kidney ACE2 activity in rats with subtotal nephrectomy.

Authors:  Elena Velkoska; Sheila K Patel; Karen Griggs; Raelene J Pickering; Chris Tikellis; Louise M Burrell
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

Review 4.  Leptin and its actions on reproduction in males.

Authors:  Ifrah Alam Malik; Damayanthi Durairajanayagam; Harbindar Jeet Singh
Journal:  Asian J Androl       Date:  2019 May-Jun       Impact factor: 3.285

5.  Modification effect of sex and obesity on the correlation of LEP polymorphisms with leptin levels in Taiwanese obese women.

Authors:  De-Min Duan; Jing-Yi Jhang; Semon Wu; Ming-Sheng Teng; Lung-An Hsu; Yu-Lin Ko
Journal:  Mol Genet Genomic Med       Date:  2020-01-08       Impact factor: 2.183

Review 6.  The Identikit of Patient at Risk for Severe COVID-19 and Death: The Dysregulation of Renin-Angiotensin System as the Common Theme.

Authors:  Riccardo Sarzani; Massimiliano Allevi; Federico Giulietti; Chiara Di Pentima; Serena Re; Piero Giordano; Francesco Spannella
Journal:  J Clin Med       Date:  2021-12-15       Impact factor: 4.964

Review 7.  Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).

Authors:  Arno R Bourgonje; Amaal E Abdulle; Wim Timens; Jan-Luuk Hillebrands; Gerjan J Navis; Sanne J Gordijn; Marieke C Bolling; Gerard Dijkstra; Adriaan A Voors; Albert Dme Osterhaus; Peter Hj van der Voort; Douwe J Mulder; Harry van Goor
Journal:  J Pathol       Date:  2020-06-10       Impact factor: 9.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.